<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Pharmx Technologies Limited — News on 6ix</title>
    <link>https://6ix.com/company/pharmx-technologies-limited</link>
    <description>Latest news and press releases for Pharmx Technologies Limited on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 25 Feb 2026 02:53:23 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/pharmx-technologies-limited" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683668a978dffbe2df15ecf7.webp</url>
      <title>Pharmx Technologies Limited</title>
      <link>https://6ix.com/company/pharmx-technologies-limited</link>
    </image>
    <item>
      <title>H1 FY26 Investor Presentation</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/h1-fy26-investor-presentation-3</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/h1-fy26-investor-presentation-3</guid>
      <pubDate>Wed, 25 Feb 2026 02:53:23 GMT</pubDate>
      <description>H1 FY26 Investor Presentation</description>
    </item>
    <item>
      <title>Half Yearly Reports &amp; Accounts</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/half-yearly-reports-and-accounts-7</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/half-yearly-reports-and-accounts-7</guid>
      <pubDate>Wed, 25 Feb 2026 02:47:23 GMT</pubDate>
      <description>Half Yearly Reports &amp; Accounts</description>
    </item>
    <item>
      <title>H1 FY26 Results Announcement</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/h1-fy26-results-announcement-8</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/h1-fy26-results-announcement-8</guid>
      <pubDate>Wed, 25 Feb 2026 02:47:23 GMT</pubDate>
      <description>H1 FY26 Results Announcement</description>
    </item>
    <item>
      <title>Pharmx and Sigma enter multi-year strategic alliance</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/pharmx-and-sigma-enter-multi-year-strategic-alliance</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/pharmx-and-sigma-enter-multi-year-strategic-alliance</guid>
      <pubDate>Mon, 23 Feb 2026 02:48:16 GMT</pubDate>
      <description>Pharmx and Sigma enter multi-year strategic alliance</description>
    </item>
    <item>
      <title>Investor Presentation</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/investor-presentation-312</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/investor-presentation-312</guid>
      <pubDate>Wed, 20 Aug 2025 03:30:18 GMT</pubDate>
      <description>Investor Presentation</description>
    </item>
    <item>
      <title>FY25 Results</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/fy25-results-6</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/fy25-results-6</guid>
      <pubDate>Wed, 20 Aug 2025 03:29:34 GMT</pubDate>
      <description>FY25 Results</description>
    </item>
    <item>
      <title>Appendix 4E &amp; FY2025 Annual Report</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/appendix-4e-and-fy2025-annual-report-3</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/appendix-4e-and-fy2025-annual-report-3</guid>
      <pubDate>Wed, 20 Aug 2025 03:24:33 GMT</pubDate>
      <description>Appendix 4E &amp; FY2025 Annual Report</description>
    </item>
    <item>
      <title>Reinstatement to Quotation</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/reinstatement-to-quotation-97</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/reinstatement-to-quotation-97</guid>
      <pubDate>Fri, 11 Jul 2025 11:20:08 GMT</pubDate>
      <description>Reinstatement to Quotation</description>
    </item>
    <item>
      <title>Suspension from Quotation</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/suspension-from-quotation-113</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/suspension-from-quotation-113</guid>
      <pubDate>Fri, 11 Jul 2025 10:33:13 GMT</pubDate>
      <description>Suspension from Quotation</description>
    </item>
    <item>
      <title>Trading Halt</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/trading-halt-589</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/trading-halt-589</guid>
      <pubDate>Fri, 11 Jul 2025 05:22:11 GMT</pubDate>
      <description>Trading Halt</description>
    </item>
    <item>
      <title>Pause in trading</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/pause-in-trading-358</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/pause-in-trading-358</guid>
      <pubDate>Fri, 11 Jul 2025 04:19:13 GMT</pubDate>
      <description>Pause in trading</description>
    </item>
    <item>
      <title>NDSS Agreement Renewal and Supplier Growth Momentum</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/ndss-agreement-renewal-and-supplier-growth-momentum</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/ndss-agreement-renewal-and-supplier-growth-momentum</guid>
      <pubDate>Fri, 11 Jul 2025 03:11:04 GMT</pubDate>
      <description>NDSS Agreement Renewal and Supplier Growth Momentum</description>
    </item>
    <item>
      <title>H1 FY25 Results Announcement</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/h1-fy25-results-announcement-8</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/h1-fy25-results-announcement-8</guid>
      <pubDate>Wed, 19 Feb 2025 03:07:22 GMT</pubDate>
      <description>H1 FY25 Results Announcement</description>
    </item>
    <item>
      <title>H1 FY25 Investor Presentation</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/h1-fy25-investor-presentation-4</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/h1-fy25-investor-presentation-4</guid>
      <pubDate>Wed, 19 Feb 2025 03:07:21 GMT</pubDate>
      <description>H1 FY25 Investor Presentation</description>
    </item>
    <item>
      <title>Half Yearly Report and Accounts</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/half-yearly-report-and-accounts-263</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/half-yearly-report-and-accounts-263</guid>
      <pubDate>Wed, 19 Feb 2025 03:06:07 GMT</pubDate>
      <description>Half Yearly Report and Accounts</description>
    </item>
    <item>
      <title>Pharmx announces strategic partnership with Toniq</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/pharmx-announces-strategic-partnership-with-toniq</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/pharmx-announces-strategic-partnership-with-toniq</guid>
      <pubDate>Tue, 18 Feb 2025 05:08:11 GMT</pubDate>
      <description>Pharmx announces strategic partnership with Toniq</description>
    </item>
    <item>
      <title>2024 Annual Report and Appendix 4E</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/2024-annual-report-and-appendix-4e-1</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/2024-annual-report-and-appendix-4e-1</guid>
      <pubDate>Tue, 27 Aug 2024 02:54:35 GMT</pubDate>
      <description>2024 Annual Report and Appendix 4E</description>
    </item>
    <item>
      <title>FY24 Results</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/fy24-results-5</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/fy24-results-5</guid>
      <pubDate>Tue, 27 Aug 2024 02:54:34 GMT</pubDate>
      <description>FY24 Results</description>
    </item>
    <item>
      <title>Update on Fred Appeals in Legal Proceedings</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/update-on-fred-appeals-in-legal-proceedings</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/update-on-fred-appeals-in-legal-proceedings</guid>
      <pubDate>Fri, 09 Aug 2024 03:42:05 GMT</pubDate>
      <description>Update on Fred Appeals in Legal Proceedings</description>
    </item>
    <item>
      <title>ATO confirms tax implications of return of share capital</title>
      <link>https://6ix.com/company/pharmx-technologies-limited/news/ato-confirms-tax-implications-of-return-of-share-capital</link>
      <guid isPermaLink="true">https://6ix.com/company/pharmx-technologies-limited/news/ato-confirms-tax-implications-of-return-of-share-capital</guid>
      <pubDate>Thu, 18 Jul 2024 03:11:06 GMT</pubDate>
      <description>ATO confirms tax implications of return of share capital</description>
    </item>
  </channel>
</rss>